Danyi Wen, President & CEO of Shanghai LIDE Co. Ltd. Register on 2011, Shanghai LIDE focus on providing services and biomarker product R&D to support “Personalized Precision Medicine”. There are two subsidiary companies under Shanghai LIDE: Xian LIDE Biotech and Shanghai LIWEN Clinical Testing Lab. Shanghai LIDE was public listed on New Third Board (Over the counter trading) on Aug 2016.

B.S from the Forth Military Medical University； M.S from Peking Union Medical University/Chinese Academy of Medical Sciences；MBA from Suffolk University; Post-Doc and Instructor of Medicine at Harvard Medical School (Brigham & Women’s Hospital); 12 years industry experience at Millennium Pharmaceutical, Biogen-Idec. Returning back to China on 2007 as VP of Biology at Shanghai ChemPartner. Founded Shanghai LIDE Biotech at the end of 2011.

Adjourn professor of Beijing Xiehe Hospital and School of Pharmacy of Fudan University; Editor of “Progress in Pharmaceutical Sciences”; Associate of Chinese anti-cancer Association (society of Liver, bile, Pancreatic); Vice Group Leader of CMBA Tissue Bank Society, PDX Group.

2013 Danyi was elected as “Shanghai Thousand Talent Expert”